Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer

Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is standard of care for locally advanced esophageal cancer in many countries. After nCRT up to one third of all patients have a pathologically complete response in the resection specimen, posing an ethical impe